Complete response of early gastric cancer to uracil and tegafur

被引:0
|
作者
Kazuya Akahoshi
Yoshiharu Chijiiwa
Syuji Hamada
Keiichi Hara
Kazuhiko Nakamura
Hajime Nawata
Noriaki Matsui
机构
[1] Third Department of Internal Medicine,
[2] Faculty of Medicine,undefined
[3] Kyushu University,undefined
[4] Fukuoka,undefined
[5] Japan,undefined
[6] Second Department of Pathology,undefined
[7] Faculty of Medicine,undefined
[8] Kyushu University,undefined
[9] Fukuoka,undefined
[10] Japan,undefined
来源
关键词
Key words: early gastric cancer; UFT; complete response;
D O I
暂无
中图分类号
学科分类号
摘要
A 74-year-old Japanese woman with early gastric cancer was successfully treated with uracil and tegafur (UFT). She was diagnosed by endoscopy (including endoscopic biopsy and endosonography) with an early gastric cancer, type IIa + IIc, on the greater curvature of the angulus. Surgical procedures or endoscopic therapy could not be performed because the patient had severe ischemic heart disease. Therefore, chemotherapy with UFT was administered at 300 mg/day for 15 months. Follow-up endoscopy, endosonography, and biopsy showed disappearance of the gastric cancer. To our knowledge, this is the first case report of the complete response of an early gastric cancer to UFT in the English-language literature.
引用
收藏
页码:864 / 867
页数:3
相关论文
共 50 条
  • [31] The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
    S E Ward
    E Kaltenthaler
    J Cowan
    M Marples
    B Orr
    M T Seymour
    British Journal of Cancer, 2006, 95 : 27 - 34
  • [32] Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience
    Yen, Hung-Hsuan
    Chen, Chiung-Nien
    Yeh, Chi-Chuan
    Lai, I-Rue
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [33] Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial
    Nakajima, T
    Nashimoto, A
    Kitamura, M
    Kito, T
    Iwanaga, T
    Okabayashi, K
    Goto, M
    LANCET, 1999, 354 (9175): : 273 - 277
  • [34] The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
    Ward, S. E.
    Kaltenthaler, E.
    Cowan, J.
    Marples, M.
    Orr, B.
    Seymour, M. T.
    BRITISH JOURNAL OF CANCER, 2006, 95 (01) : 27 - 34
  • [35] Uracil/tegafur plus oral calcium folinate in advanced breast cancer
    Richardet, E
    Pedraza, C
    Mickiewicz, E
    Lerzo, G
    Bonamasa, M
    Coppola, F
    Elli, A
    Uranga, G
    Jovtis, S
    Bruno, M
    Ventriglia, M
    Cuevas, MA
    Alvarez, AM
    Suarez, LA
    Fein, L
    ONCOLOGY-NEW YORK, 1999, 13 (07): : 96 - 97
  • [36] Gemcitabine Combined With Uracil-Tegafur in Patients With Advanced Pancreatic Cancer
    Coskun, Ugur
    Alkis, Necati
    Celenkoglu, Gokhan
    Buyukberber, Sueleyman
    Ozkan, Metin
    Camci, Celalettin
    Uner, Aytug
    Er, Ozlem
    Aslan, Ulkue Yalcintas
    Sevinc, Alper
    Tokluoglu, Saadet
    Ozturk, Banu
    Yildiz, Ramazan
    Benekli, Mustafa
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (08) : 761 - 764
  • [37] The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
    Almond, J.
    Ralston, S.
    BRITISH JOURNAL OF CANCER, 2007, 96 (09) : 1489 - 1489
  • [38] Of what value is uracil/tegafur plus leucovorin to colorectal cancer patients?
    Friedman, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3574 - 3575
  • [39] ASO Author Reflections: Tegafur-Uracil in Advanced Oral Cancer
    Hsieh, Ming-Yu
    Chen, Mu-Kuan
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 899 - 900
  • [40] Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin
    Suga, S
    Iwase, H
    Shimada, M
    Nishio, Y
    Ichihara, T
    Ichihara, S
    Kusugami, K
    Saito, H
    INTERNAL MEDICINE, 1996, 35 (12) : 930 - 936